Drug intelligence / Profile preview

Zizhu ointment (045a35)

Development stage: Unknown
Lead developer: Shuguang Hospital
Administration: Topical

Overview

Zizhu ointment is a traditional Chinese medicine (TCM) topical preparation developed by Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. It is primarily used for the treatment of chronic skin ulcers, including diabetic foot ulcers and venous ulcers of the lower extremities. The ointment is designed to promote wound healing, reduce inflammation, and potentially improve local microcirculation. Clinical studies have investigated its efficacy both as a monotherapy and in combination with other treatments like varicose vein surgery to accelerate the healing of recalcitrant ulcers.

Other names: Zizhu Gao紫朱膏

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)

Beyond the preview

Go deeper on Zizhu ointment (045a35).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zizhu ointment (045a35).

Explore the full profile